Athira Pharma, Inc.
ATHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $91 | $96 | $111 |
| Short-Term Investments | $3 | $57 | $104 | $143 |
| Receivables | $0 | $2 | $1 | $2 |
| Inventory | $0 | $0 | -$1 | $0 |
| Other Curr. Assets | $4 | $6 | $7 | $5 |
| Total Curr. Assets | $55 | $155 | $208 | $261 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $45 | $66 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $6 | $51 | $71 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $59 | $160 | $258 | $332 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $3 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $28 | $19 | $8 |
| Total Curr. Liab. | $13 | $29 | $21 | $9 |
| LT Debt | $1 | $1 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $2 |
| Total Liabilities | $14 | $30 | $23 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$406 | -$309 | -$192 | -$96 |
| AOCI | $0 | -$0 | -$2 | -$0 |
| Other Equity | $451 | $440 | $429 | $417 |
| Total Equity | $45 | $130 | $235 | $321 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $59 | $160 | $258 | $332 |
| Net Debt | -$47 | -$89 | -$94 | -$109 |